| P/E (FY) | — | Sales (TTM) | SEK 100,000 |
| Earnings (TTM) | -SEK 228.0M | ROE | −5.87% |
| Net Margin | −228000.00% | ROIC | −6.61% |
| Debt / Equity | — | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | — |
Flerie is a venture capital firm specializing in early-stage investments. It targets life science, biotech and pharmaceutical companies working on drug development and associated tools or applications aimed at major medical challenges, investing across Europe, the Nordics, the United States and Israel. The firm was founded in 2011 and is based in Stockholm, with an additional office in London.
No price history for FLERIE.ST — it is outside the redistributable backbone (BYOK data required), so price statistics are unavailable.
No return history for FLERIE.ST, so risk analytics are unavailable.
No same-industry peers in the universe for FLERIE.ST.
